Karin Jooss

(DR. Karin Jooss Ph.D.)

Currently holds positions in Gritstone Oncology Inc and Fate Therapeutics Inc

Positions

Position Company Period
Executive Vice President - Research, Chief Scientific Officer Gritstone Oncology Inc April 1, 2016 -
Independent Director Fate Therapeutics Inc March 18, 2019 -
Karin Jooss's trades of Gritstone Oncology Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-05-17 2024-05-16
S Sale
13,749 -2.0%
0.75
USD 10,288 		13,749 -2.0% 0.75 USD 10,288
2022-06-06 2022-06-03
S Sale
1,483 -55.3%
22.82
USD 33,842 		1,483 -55.3% 22.82 USD 33,842
// ... existing code ... // ... rest of the file ...